Merck KGaA

1MRK

Company Profile

  • Business description

    Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

  • Contact

    Frankfurter Strasse 250
    DarmstadtHE64293
    DEU

    T: +49 6151720

    https://www.emdgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    63,160

Stocks News & Analysis

stocks

Is this still an ASX share to own forever?

Find out how this defensive player has fared after earnings.
stocks

After earnings, is Nvidia stock a buy, a sell, or fairly valued?

No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks

Short-term pain for long-term gain for undervalued ASX share

Cost reductions lower our profit estimates but should lead to improved long-term outcomes.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,010.10117.10-1.28%
CAC 407,719.7165.460.86%
DAX 4023,594.80107.470.46%
Dow JONES (US)45,271.2324.58-0.05%
FTSE 1009,177.9961.300.67%
HKSE25,343.43153.12-0.60%
NASDAQ21,497.73218.101.02%
Nikkei 22541,938.89371.60-0.88%
NZX 50 Index13,045.6729.14-0.22%
S&P 5006,448.2632.720.51%
S&P/ASX 2008,738.80120.20-1.36%
SSE Composite Index3,813.5644.58-1.16%

Market Movers